Consideraciones en torno a las Guías USA 2017 de hipertensión arterial

The 2017 Guidelines on hypertension of the American College of Cardiology and American Heart Association, which proposed values of 130/80 mmHg as the cutoff points for the onset of hypertension, aroused great interest. This recommendation is based in the SPRINT study (The Systolic Pressure Intervent...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fasce,Eduardo, Zarate,Luis Hernán, Ortiz,Liliana
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2018
Materias:	Guideline Hypertension Practice Guideline
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001101317
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872018001101317
record_format	dspace
spelling	oai:scielo:S0034-988720180011013172019-02-13Consideraciones en torno a las Guías USA 2017 de hipertensión arterialFasce,EduardoZarate,Luis HernánOrtiz,Liliana Guideline Hypertension Practice Guideline The 2017 Guidelines on hypertension of the American College of Cardiology and American Heart Association, which proposed values of 130/80 mmHg as the cutoff points for the onset of hypertension, aroused great interest. This recommendation is based in the SPRINT study (The Systolic Pressure Intervention Trial), which included hypertensive patients over 50 years of age, non-diabetic, without a history of stroke and with a low representation of subjects with a history of coronary artery disease (16%). A group with intensive anti-hypertensive therapy (pressure achieved 121.5 mmHg) achieved a significantly lower cardiovascular risk as compared with a group with standard therapy (pressure achieved 134.6 mmHg). The Guide proposes immediate pharmacological therapy in diabetic hypertensive patients, in those with stage 3 chronic kidney disease or with persistent albuminuria, and in patients with atherosclerotic disease. The Guideline does not include the management of isolated systolic hypertension of the elderly and did not consider studies that show an increased risk when pressure is reduced below 130/80 mmHg in patients with coronary disease, peripheral vascular disease, diabetes mellitus or chronic renal failure. The new classification of hypertension would increase the number of hypertensive patients in our country by more than one million, would increase the risk associated with diastolic pressure reductions in older adults and ignores the evidence indicating a risk associated with reductions below 130/80 mmHg in patients with diabetes, with chronic renal failure or with atherosclerotic disease. Therefore, it is advisable to maintain a threshold of 140/90 mmHg and perform a careful and gradual management of blood pressure in the latter group of hypertensive patients.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.146 n.11 20182018-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001101317es10.4067/S0034-98872018001101317
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Guideline Hypertension Practice Guideline
spellingShingle	Guideline Hypertension Practice Guideline Fasce,Eduardo Zarate,Luis Hernán Ortiz,Liliana Consideraciones en torno a las Guías USA 2017 de hipertensión arterial
description	The 2017 Guidelines on hypertension of the American College of Cardiology and American Heart Association, which proposed values of 130/80 mmHg as the cutoff points for the onset of hypertension, aroused great interest. This recommendation is based in the SPRINT study (The Systolic Pressure Intervention Trial), which included hypertensive patients over 50 years of age, non-diabetic, without a history of stroke and with a low representation of subjects with a history of coronary artery disease (16%). A group with intensive anti-hypertensive therapy (pressure achieved 121.5 mmHg) achieved a significantly lower cardiovascular risk as compared with a group with standard therapy (pressure achieved 134.6 mmHg). The Guide proposes immediate pharmacological therapy in diabetic hypertensive patients, in those with stage 3 chronic kidney disease or with persistent albuminuria, and in patients with atherosclerotic disease. The Guideline does not include the management of isolated systolic hypertension of the elderly and did not consider studies that show an increased risk when pressure is reduced below 130/80 mmHg in patients with coronary disease, peripheral vascular disease, diabetes mellitus or chronic renal failure. The new classification of hypertension would increase the number of hypertensive patients in our country by more than one million, would increase the risk associated with diastolic pressure reductions in older adults and ignores the evidence indicating a risk associated with reductions below 130/80 mmHg in patients with diabetes, with chronic renal failure or with atherosclerotic disease. Therefore, it is advisable to maintain a threshold of 140/90 mmHg and perform a careful and gradual management of blood pressure in the latter group of hypertensive patients.
author	Fasce,Eduardo Zarate,Luis Hernán Ortiz,Liliana
author_facet	Fasce,Eduardo Zarate,Luis Hernán Ortiz,Liliana
author_sort	Fasce,Eduardo
title	Consideraciones en torno a las Guías USA 2017 de hipertensión arterial
title_short	Consideraciones en torno a las Guías USA 2017 de hipertensión arterial
title_full	Consideraciones en torno a las Guías USA 2017 de hipertensión arterial
title_fullStr	Consideraciones en torno a las Guías USA 2017 de hipertensión arterial
title_full_unstemmed	Consideraciones en torno a las Guías USA 2017 de hipertensión arterial
title_sort	consideraciones en torno a las guías usa 2017 de hipertensión arterial
publisher	Sociedad Médica de Santiago
publishDate	2018
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001101317
work_keys_str_mv	AT fasceeduardo consideracionesentornoalasguiasusa2017dehipertensionarterial AT zarateluishernan consideracionesentornoalasguiasusa2017dehipertensionarterial AT ortizliliana consideracionesentornoalasguiasusa2017dehipertensionarterial
_version_	1718437033832087552

Consideraciones en torno a las Guías USA 2017 de hipertensión arterial

Ejemplares similares